SEC Form D private-offering filing

Lighthouse Pharmaceuticals, Inc.

Name: Lighthouse Pharmaceuticals, Inc. - new SEC Form D private-offering filing, Novato, CA
Published: 2026-05-07

A new SEC Form D private-offering notice from Novato, CA, a $15,206,800 filer-stated offering target in Biotech. The source filing is one click away.

Lighthouse Pharmaceuticals, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing precision therapeutics, including LHP588, a gingipain inhibitor in Phase 2 trials for P. gingivalis positive Alzheimer's disease

Filed 2026-05-07Filed to raise $15,206,800First money in 2026-04-22Raised so far $15,206,800HQ (as filed) Novato, CASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified lighthousepharma.com↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.